目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Chemiluminescence Immunoassay Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Chemiluminescence Immunoassay Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape

Chapter 4. Chemiluminescence Immunoassay Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Chemiluminescence Immunoassay Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Instruments
4.3.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Automated
4.3.2.1. Automated Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. Semi-automated
4.3.3.1. Semi-automated Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Consumables
4.4.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Software & Services
4.5.1. Software & Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Chemiluminescence Immunoassay Market: Sample Type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Chemiluminescence Immunoassay Market: Sample Type Movement Analysis, 2023 & 2030 (USD Million)
5.3. Blood
5.3.1. Blood Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Urine
5.4.1. Urine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Saliva
5.5.1. Saliva Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Other Sample Types
5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Chemiluminescence Immunoassay Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Chemiluminescence Immunoassay Market: Application Movement Analysis, 2023 & 2030 (USD Million)
6.3. Therapeutic Drug Monitoring
6.3.1. Therapeutic Drug Monitoring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Oncology
6.4.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Cardiology
6.5.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Endocrinology
6.6.1. Endocrinology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Infectious Disease
6.7.1. Infectious Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Autoimmune Disease
6.8.1. Autoimmune Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9. Other Applications
6.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Chemiluminescence Immunoassay Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Chemiluminescence Immunoassay Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
7.3. Hospitals
7.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Clinical Laboratories
7.4.1. Clinical Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Pharmaceutical & Biotechnology Companies
7.5.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Other End Uses
7.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Chemiluminescence Immunoassay Market: Regional Estimates & Trend Analysis
8.1. Chemiluminescence Immunoassay Market Share, By Region, 2023 & 2030 (USD Million)
8.2. North America
8.2.1. North America Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.3. Canada
8.2.3.1. Canada Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.4. Mexico
8.2.4.1. Mexico Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1. Europe Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.2. UK
8.3.2.1. UK Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Germany Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.4. France
8.3.4.1. France Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.5. Italy
8.3.5.1. Italy Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.6. Spain
8.3.6.1. Spain Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Denmark Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Sweden Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.9. Norway
8.3.9.1. Norway Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.2. Japan
8.4.2.1. Japan Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.3. China
8.4.3.1. China Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.4. India
8.4.4.1. India Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.5. Australia
8.4.5.1. Australia Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.6. South Korea
8.4.6.1. South Korea Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.7. Thailand
8.4.7.1. Thailand Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Brazil Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.3. Argentina
8.5.3.1. Argentina Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Middle East and Africa
8.6.1. Middle East and Africa Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.2. South Africa
8.6.2.1. South Africa Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Saudi Arabia Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.4. UAE
8.6.4.1. UAE Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Kuwait Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
9.4.1. Abbott Laboratories
9.4.1.1. Participant’s Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Recent Developments/Strategic Initiatives
9.4.2. Beckman Coulter Inc.
9.4.2.1. Participant’s Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Recent Developments/Strategic Initiatives
9.4.3. DiaSorin S.p.A.
9.4.3.1. Participant’s Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Recent Developments/Strategic Initiatives
9.4.4. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
9.4.4.1. Participant’s Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Recent Developments/Strategic Initiatives
9.4.5. F. Hoffmann-La Roche AG
9.4.5.1. Participant’s Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Recent Developments/Strategic Initiatives
9.4.6. Siemens Healthineers
9.4.6.1. Participant’s Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Recent Developments/Strategic Initiatives
9.4.7. Ortho Clinical Diagnostics
9.4.7.1. Participant’s Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Recent Developments/Strategic Initiatives